HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Improving South African Government Workers' Capacities to Deliver HIV Interventions [Phase 2, Phase 3]
Phase 2/3 clinical trial update assessing interventions to improve delivery of HIV-related interventions among South African government work…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Combination Therapy With VRC01 and 10-1074 in HIV-Infected Individuals Undergoing Sequential Treatment Interruptions [Phase 1]
Phase 1 trial investigating combination therapy with VRC01 and 10-1074 in HIV-infected individuals undergoing sequential treatment interrupt…
-
FDA approval · 2021-10-07FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for BIKTARVY (bictegravir, emtricitabine, and tenofovir alafenamide fumarate) submitted by Gilea…
-
FDA approval · 2021-10-07FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original-application generic combination emtricitabine and tenofovir disoproxil fumarate for treatm…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Test Albuvirtide in Experienced Patients [Phase 3]
Phase 3 trial update for albuvirtide in experienced HIV/AIDS patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition [Phase 2, Phase 3]
A clinical trial update exploring strategies to reduce mortality among HIV-infected and HIV-exposed children admitted with severe acute maln…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide [Phase 4]
Phase 4 trial updating a urine assay to measure tenofovir levels in patients taking tenofovir alafenamide; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects [Phase 2]
Phase 2 clinical trial update evaluating long-acting maintenance therapy with albuvirtide and 3BNC117 in virologically suppressed HIV-1-infe…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM [Phase 2]
Phase 2 trial update investigating linezolid, aspirin, and enhanced-dose rifampicin for HIV-associated tuberculous meningitis; study complet…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Patch Study - Intervention for HIV Positive Smokers [NA]
A completed clinical trial study titled 'Patch Study - Intervention for HIV Positive Smokers' with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: PrEP in Breastfeeding Study [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial updating on pre-exposure prophylaxis during breastfeeding.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: A Stigma Reduction Intervention at Time of Entry Into Antenatal Care to Improve PMTCT Services in Tanzania [NA]
Completed clinical trial evaluating a stigma reduction intervention at entry into antenatal care to improve PMTCT services in Tanzania.
-
CLINICAL_TRIALS withdrawal · 2021-09-20Clinical Trial Update: A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects [Phase 4]
A Phase 4 pharmacokinetic/pharmacodynamic study evaluating interactions between bictegravir, tenofovir alafenamide, and rifapentine in healt…
-
FDA approval · 2021-09-15FDA Approved: DESCOVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for DESCOVY (emtricitabine and tenofovir alafenamide) submitted by Gilead Sciences, Inc., likely…
-
FDA approval · 2021-09-13FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) from Gilead Sci…
-
FDA approval · 2021-09-13FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods' generic fixed-dose tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate through an originalA…
-
FDA approval · 2021-09-10FDA Approved: ODEFSEY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for ODEFSEY, a fixed-dose combination antiretroviral tablet containing emtricitabine, rilpivirin…
-
FDA approval · 2021-09-10FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for BIKTARVY (bictegravir/emtricitabine/tenofovir alafenamide) from Gilead Sciences, Inc., updating …
-
FDA approval · 2021-09-09FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) from Gilead S…
-
FDA approval · 2021-09-09FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for TYBOST (cobicistat) from Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs [NA]
Clinical trial update about stigma, risk behaviors, and health care among HIV-infected people who inject drugs in Russia; the study is compl…
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings [Phase 3]
A Phase 3 trial assessing the efficacy and safety of a dolutegravir-based regimen for initial management of HIV-1 infection in adults in res…
-
FDA approval · 2021-08-17FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP.
-
FDA approval · 2021-08-17FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: The Healthy Life Choices Project in HIV-Positive Patients [Phase 2]
Phase 2 clinical trial update for the Healthy Life Choices Project in HIV-positive patients completed.